DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20164186

Maternal and fetal outcomes in HIV positive pregnant female

Mahim Mittal, Ashutosh Kumar Mall, Yash Gopal Sharma

Abstract


Background: Vertical Transmission is still not an uncommon mode of HIV transmission. HIV and its treatment can also affect maternal and fetal outcomes. We aimed to study incidence and factors of MTCT and maternal and fetal outcomes with the current standard of care.

Methods: It was an observational study, at BRD medical college Gorakhpur. Pregnant, HIV positive females consenting for the study were enrolled. Follow up was up to 6 months post-delivery. Infant testing for transmission was done at 6 months.

Results: A total 35 HIV positive pregnant female were studied. Follow up could be completed in only 29 patients. Four (13.79%) infants had HIV DNA detectable in whole blood at 6 months. Transmission was 16.6% in group taking ART for <3 month as compared to 11.7% in group taking ART for >3 months, 25% in mixed feeding group vs. 12% in exclusive breast feeding and 16.6% in NVD group vs. 9% in LSCS. Incidence of Preterm delivery was higher in group who took ART for longer duration. IUGR was present in 10/29 (27%) and growth failure in 12/29 (41%) infants.

Conclusions: Longer ART duration and cesarean section delivery were more effective in preventing MTCT. Even exclusive breast feeding could result in MTCT. HIV exposure in utero may lead to IUGR. ART has no deleterious or positive effect on fetal growth but may be associated with preterm delivery. Better patient education will probably lead to earlier diagnosis and initiation of therapy to prevent transmission, and also to better fetal and infant outcomes.


Keywords


ART, IUGR, LSCS, MTCT, NVD

Full Text:

PDF

References


Prevention of Parent to Child Transmission (PPTCT) of HIV using Multi Drug Anti-retroviral Regimen in India, December. 2013.

Gray GE, McIntyre J. Pregnancy plus HIV and pregnancy. British Med J. 2007; 334:950-3.

Thorne C, Patel D, Newell ML. Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS. 2004;18(17):2337-9.

Kouanda S, Tougri H, Cisse M, Simpore J, Pietra V, Doulougou B, et al. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso. AIDS Care. 2010;22(7):843-50.

Marazzi MC, Guidotti G, Palombi L. An integrated faith-based initiative to treat HIV/AIDS in mozambique, dream study. Available at: http://www.who.int/ hiv/ pub/ casestudies/ mozambiquedream.pdf.

Iliff PJ, Piwoz EG, Tavengwa NV, Zunguza CD, Marinda ET, Nathoo KJ. Early exclusive breastfeeding reduces HIV-transmission and increases HIV-free survival. AIDS. 2005;19(7):699-708.

Reada JS. Late Postnatal Transmission of HIV-1 in Breast-Fed Children: An Individual Patient Data Meta-Analysis. J Infect Dis. 2004;189(12):2154-66.

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med. 1999; 340(13):977-87.

Townsend CL, Tookey PA, Cortina-Borja M, Peckham CS. Antiretroviral therapy and congenital abnormalities in infants born to HIV-1-infected women in the United Kingdom and Ireland, 1990 to 2003. J Acquir Immune Defic Syndr. 2006;42(1):91-4.

Ezechi OC, David AN, Gab-Okafor CV, Ohwodo H, Oladele DA, Kalejaiye OO, et al. Incidence of and socio-biologic risk factors for spontaneous preterm birth in HIV positive Nigerian women. BMC Pregnancy Childbirth. 2012;12:93.

Stratton P, Tuomala RE, Abboud R, Rodriguez E, Rich K, Pitt J, et al. Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: a report of the women and infants transmission study. J Acquir Immune Defic Syndr Hum Retroviral. 1999;20(2):179-86.

López M, Palacio M, Goncé A, Hernàndez S, Barranco FJ, García L, ET AL. Risk of intrauterine growth restriction among HIV- infected pregnant women: a cohort study. Eur J Clin Microbiol Infect Dis. 2015;34(2):223-30.

Cambrea SC, Tănase DE, Ilie MM, Diaconu S, Marcaş C, Carp, DS, et al. Can HIV Infection during Pregnancy Cause an Intrauterine Growth Restriction?” BMC Infectious Diseases. 2013;13(Suppl 1):05.

Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Newell ML, Borja MC, Peckham C, European Collaborative Study Pediatrics. 2003;111(1):e52-60.

Taguebue J, Monebenimp F, Zingg W, Mve Koh V, Atchoumi A, Gervaix A, et al. Risk Factors for Prematurity among Neonates from HIV Positive Mothers in Cameroon. World Journal of AIDS. 2011;1:1-7.

The European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: randomised clinical trial. Lancet. 1999;353:1035-9.